Nuovision completes about US$20 million in Pre-A round of financing

Nuochem is a developer of innovative drugs for the central nervous system, focusing on the development of innovative drugs for the central nervous system (CNS). Has an innovation-driven engine for AAV-based gene therapy and small molecule drug therapy. Recently, New Ocean Medical completed the Pre-A round of financing of about 20 million US dollars led by Longpan Capital. This round of financing will be used to support the construction of professional teams, as well as to accelerate the construction of CNS independent research platforms in China and the United States and the development of innovative drugs. development.

This article is reproduced from: https://www.itjuzi.com/investevent/13579369
This site is for inclusion only, and the copyright belongs to the original author.